Key result
Mobile ECG devices offer diverse lead measurements and monitoring durations for various clinical applications.
Why the study?
Despite the expanding use and advantages of mobile ECG devices, questions remain regarding data quality, as well as clinician and patient acceptance and compliance.
Mobile ECG devices offer diverse clinical applications for arrhythmia detection and prognostic risk evaluation, though challenges in data quality and user acceptance remain.
Answers are grounded in this paper and cite their sources.
Supports tailored mobile ECG selection for arrhythmia needs; extends device options while leaving data quality and acceptance challenges open.
The electrocardiogram (ECG) can now be measured using mobile devices. Mobile ECG devices, which are defined as devices capable of recording and transmitting non-standard ECGs, offer numerous advantages such as cost-effectiveness and being user-friendly. Mobile ECG can also extend recording lengths (e.g., 2 days, 14 days), which is necessary to capture important intermittent events (e.g., cardiac arrhythmias) and evaluate prognostic risk markers (e.g., prolonged corrected QT (QTc) interval). Some mobile ECG devices can even connect to broadband networks allowing patients to remotely transmit their ECG to a clinician. This article systematically examines different mobile ECG devices used in prior studies and provides a detailed assessment of five diverse yet commonly used mobile ECG devices: AliveCor KardiaMobile; AliveCor KardiaMobile 6L; iRhythm ZioPatch; Apple Smartwatch ECG; and CardioSecur System. These mobile ECG devices are diverse in the number of leads measured and the duration of monitoring. Similar to their diversity, there has been a wide range of clinical applications of mobile ECG devices. Despite significant progress, questions regarding data quality, and clinican and patient acceptance and compliance persist.
No takes yet. Share an insight, caveat, or question.
Dillon J. Dzikowicz (2023) conducted a review in Cardiac arrhythmias. Mobile ECG devices was evaluated. Mobile ECG devices, including AliveCor KardiaMobile, iRhythm ZioPatch, and Apple Smartwatch ECG, offer diverse lead measurements and monitoring durations for various clinical applications.
Synapse has enriched 10 related papers. Consider them for comparative context: